DBV Technologies | DBVT - Eigenkapital Und Reserven

Aktienkurs
21.72
Täglich Wechseln
-1.07 -4.70%
Monatlich
1.21%
Jährlich
389.19%
Q1 Prognose
20.46




Eigenkapital Und Reserven Veränderung Datum
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amarin USD 458.89M 6.03M 2025-09
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
DBV Technologies USD 52.85M 33.37M 2025-09
Esperion Therapeutics USD -451.36M 17.85M 2025-09
Galectin Therapeutics USD -83.87M 11.06M 2024-06
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Incyte USD 5.17B 516.28M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
United Therapeutics USD 7.1B 506M 2025-12